Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pitx3
|
ENSMUSG00000025229.9 | paired-like homeodomain transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_46137288_46137479 | Pitx3 | 94 | 0.948123 | 0.83 | 5.9e-15 | Click! |
chr19_46136463_46136634 | Pitx3 | 741 | 0.526532 | 0.45 | 5.8e-04 | Click! |
chr19_46148122_46148695 | Pitx3 | 82 | 0.951938 | 0.40 | 2.2e-03 | Click! |
chr19_46135357_46135577 | Pitx3 | 1822 | 0.223935 | -0.38 | 4.4e-03 | Click! |
chr19_46141211_46141374 | Pitx3 | 309 | 0.834468 | -0.36 | 7.0e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_155605299_155605479 | 29.04 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
5823 |
0.09 |
chr14_14351950_14353283 | 27.65 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr1_82816421_82816691 | 24.16 |
Gm28942 |
predicted gene 28942 |
3279 |
0.12 |
chr13_101573406_101573557 | 23.92 |
Gm19010 |
predicted gene, 19010 |
15650 |
0.16 |
chr11_58351240_58351509 | 22.96 |
Sh3bp5l |
SH3 binding domain protein 5 like |
6062 |
0.1 |
chr8_84838620_84839103 | 22.14 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
181 |
0.86 |
chr4_151957913_151958084 | 21.54 |
Dnajc11 |
DnaJ heat shock protein family (Hsp40) member C11 |
855 |
0.5 |
chr4_119028467_119028820 | 21.46 |
Gm12862 |
predicted gene 12862 |
28158 |
0.08 |
chr2_104078501_104078672 | 20.90 |
Cd59b |
CD59b antigen |
7520 |
0.11 |
chr2_153495495_153495649 | 20.68 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
2782 |
0.24 |
chr10_127135695_127135846 | 20.21 |
Gm4178 |
predicted gene 4178 |
2274 |
0.13 |
chr2_104098671_104098841 | 20.13 |
Cd59a |
CD59a antigen |
2916 |
0.17 |
chr9_15289254_15289422 | 20.09 |
4931406C07Rik |
RIKEN cDNA 4931406C07 gene |
230 |
0.77 |
chr18_21152420_21152758 | 19.89 |
Gm6378 |
predicted pseudogene 6378 |
75480 |
0.09 |
chr6_39423688_39423950 | 19.29 |
Gm25402 |
predicted gene, 25402 |
1400 |
0.3 |
chr4_38334610_38334805 | 19.08 |
Gm12380 |
predicted gene 12380 |
70789 |
0.14 |
chr11_117782445_117782614 | 18.85 |
Tmc8 |
transmembrane channel-like gene family 8 |
129 |
0.72 |
chr11_88045557_88045711 | 18.82 |
Srsf1 |
serine and arginine-rich splicing factor 1 |
1739 |
0.23 |
chr10_45583380_45583544 | 18.61 |
Gm47504 |
predicted gene, 47504 |
2243 |
0.28 |
chr14_47515855_47516006 | 18.60 |
Gm35166 |
predicted gene, 35166 |
7743 |
0.12 |
chr14_53336825_53337105 | 18.54 |
Gm43650 |
predicted gene 43650 |
6957 |
0.19 |
chr14_65145820_65146065 | 18.33 |
Extl3 |
exostosin-like glycosyltransferase 3 |
3913 |
0.18 |
chr19_24535123_24535505 | 18.30 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
20475 |
0.18 |
chr14_53729267_53729540 | 18.28 |
Trav13-3 |
T cell receptor alpha variable 13-3 |
155 |
0.94 |
chr19_5266994_5267269 | 18.16 |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
5576 |
0.09 |
chr10_93883124_93883275 | 18.12 |
Metap2 |
methionine aminopeptidase 2 |
4287 |
0.15 |
chr6_38346223_38346374 | 17.98 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
7975 |
0.13 |
chr19_10662035_10662222 | 17.78 |
Vwce |
von Willebrand factor C and EGF domains |
4139 |
0.11 |
chr4_108960317_108960468 | 17.48 |
8030443G20Rik |
RIKEN cDNA 8030443G20 gene |
11685 |
0.13 |
chr9_64792478_64792650 | 17.39 |
Dennd4a |
DENN/MADD domain containing 4A |
18776 |
0.18 |
chr16_93197838_93198066 | 16.81 |
Gm28003 |
predicted gene, 28003 |
125197 |
0.05 |
chr18_61278473_61278624 | 16.70 |
Pde6a |
phosphodiesterase 6A, cGMP-specific, rod, alpha |
3525 |
0.21 |
chr2_153259980_153260131 | 16.67 |
Pofut1 |
protein O-fucosyltransferase 1 |
2483 |
0.21 |
chr15_98586245_98586397 | 16.59 |
Gm29331 |
predicted gene 29331 |
3669 |
0.1 |
chr9_64049464_64049751 | 16.55 |
Gm25606 |
predicted gene, 25606 |
1111 |
0.4 |
chr7_100504925_100505084 | 16.53 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
6658 |
0.09 |
chr13_112749249_112749523 | 16.38 |
Slc38a9 |
solute carrier family 38, member 9 |
13776 |
0.14 |
chr1_181258241_181258397 | 16.33 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
15999 |
0.14 |
chr9_64044631_64044826 | 16.30 |
1700055C04Rik |
RIKEN cDNA 1700055C04 gene |
3263 |
0.17 |
chr15_97405026_97405208 | 16.01 |
Pced1b |
PC-esterase domain containing 1B |
43900 |
0.17 |
chr6_144669882_144670033 | 15.98 |
Sox5it |
SRY (sex determining region Y)-box 5, intronic transcript |
2763 |
0.24 |
chr11_113680704_113680865 | 15.87 |
Gm11693 |
predicted gene 11693 |
2254 |
0.18 |
chrX_7966047_7966219 | 15.74 |
Gata1 |
GATA binding protein 1 |
1777 |
0.17 |
chr4_33471238_33471389 | 15.60 |
Gm11935 |
predicted gene 11935 |
18424 |
0.21 |
chr4_132269873_132270275 | 15.51 |
Gm28872 |
predicted gene 28872 |
18 |
0.62 |
chr12_3283870_3284036 | 15.44 |
Rab10 |
RAB10, member RAS oncogene family |
26016 |
0.13 |
chr7_44768239_44768409 | 15.44 |
Vrk3 |
vaccinia related kinase 3 |
11338 |
0.08 |
chr16_32611664_32611815 | 15.42 |
Tfrc |
transferrin receptor |
2489 |
0.22 |
chr15_62159390_62159541 | 15.20 |
Pvt1 |
Pvt1 oncogene |
18710 |
0.25 |
chr16_96906344_96906497 | 15.14 |
Gm32432 |
predicted gene, 32432 |
12312 |
0.29 |
chr1_64788239_64788443 | 15.01 |
Plekhm3 |
pleckstrin homology domain containing, family M, member 3 |
48423 |
0.11 |
chr1_23417975_23418236 | 15.00 |
Ogfrl1 |
opioid growth factor receptor-like 1 |
20333 |
0.19 |
chr1_125551638_125551808 | 14.90 |
Slc35f5 |
solute carrier family 35, member F5 |
8872 |
0.27 |
chr16_32633733_32633955 | 14.86 |
Tfrc |
transferrin receptor |
9402 |
0.14 |
chr1_156987967_156988148 | 14.84 |
4930439D14Rik |
RIKEN cDNA 4930439D14 gene |
48219 |
0.1 |
chr6_108529257_108529443 | 14.81 |
Gm44040 |
predicted gene, 44040 |
3663 |
0.19 |
chr5_124052764_124052929 | 14.78 |
Gm43661 |
predicted gene 43661 |
494 |
0.66 |
chr4_145221682_145222086 | 14.75 |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
24986 |
0.17 |
chr5_34572994_34573157 | 14.73 |
Add1 |
adducin 1 (alpha) |
589 |
0.49 |
chr4_132427645_132427803 | 14.56 |
Phactr4 |
phosphatase and actin regulator 4 |
5235 |
0.11 |
chr8_123979372_123979523 | 14.50 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
3675 |
0.13 |
chr4_118080595_118080757 | 14.20 |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
48794 |
0.11 |
chr4_109439863_109440291 | 14.17 |
Ttc39a |
tetratricopeptide repeat domain 39A |
19135 |
0.15 |
chr2_131518798_131519083 | 14.01 |
Smox |
spermine oxidase |
1246 |
0.45 |
chr2_122138576_122138727 | 13.90 |
B2m |
beta-2 microglobulin |
9035 |
0.12 |
chr15_81859577_81860266 | 13.87 |
Tob2 |
transducer of ERBB2, 2 |
1125 |
0.28 |
chr13_23426879_23427032 | 13.83 |
Abt1 |
activator of basal transcription 1 |
3089 |
0.11 |
chr19_41906400_41906712 | 13.79 |
Gm46644 |
predicted gene, 46644 |
3667 |
0.13 |
chr11_101645405_101645795 | 13.76 |
Gm23971 |
predicted gene, 23971 |
330 |
0.75 |
chr4_57794014_57794346 | 13.51 |
Pakap |
paralemmin A kinase anchor protein |
12000 |
0.19 |
chr2_103888048_103888210 | 13.50 |
Gm13876 |
predicted gene 13876 |
195 |
0.9 |
chr13_99019515_99019689 | 13.40 |
A930014D07Rik |
RIKEN cDNA A930014D07 gene |
12503 |
0.12 |
chr5_112244308_112244475 | 13.38 |
Cryba4 |
crystallin, beta A4 |
6771 |
0.12 |
chrX_150547265_150547522 | 13.35 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
18 |
0.52 |
chr3_14828893_14829089 | 13.28 |
Car1 |
carbonic anhydrase 1 |
20623 |
0.15 |
chr13_22040415_22040853 | 13.23 |
H4c9 |
H4 clustered histone 9 |
728 |
0.27 |
chr13_73475366_73476070 | 13.21 |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
3967 |
0.26 |
chr4_116655144_116655442 | 13.12 |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
3613 |
0.13 |
chr1_184669303_184669460 | 13.11 |
Gm38358 |
predicted gene, 38358 |
25653 |
0.13 |
chr4_41353370_41353539 | 13.08 |
Ubap1 |
ubiquitin-associated protein 1 |
4406 |
0.14 |
chr2_163575250_163575556 | 12.98 |
Hnf4a |
hepatic nuclear factor 4, alpha |
25320 |
0.11 |
chr6_28737770_28737921 | 12.95 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
26845 |
0.19 |
chr10_63060801_63060952 | 12.86 |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
147 |
0.91 |
chr17_84148045_84148248 | 12.83 |
Gm19696 |
predicted gene, 19696 |
8280 |
0.17 |
chr2_22587496_22588353 | 12.73 |
Gm13341 |
predicted gene 13341 |
38 |
0.95 |
chr5_140645168_140645484 | 12.71 |
Ttyh3 |
tweety family member 3 |
3671 |
0.17 |
chr9_58249300_58249456 | 12.70 |
Pml |
promyelocytic leukemia |
245 |
0.88 |
chr5_118488405_118488562 | 12.65 |
Gm15754 |
predicted gene 15754 |
1516 |
0.42 |
chr11_11729316_11729485 | 12.64 |
Gm12000 |
predicted gene 12000 |
32961 |
0.14 |
chr4_139334727_139334899 | 12.61 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
2367 |
0.12 |
chr19_37667983_37668152 | 12.54 |
Cyp26c1 |
cytochrome P450, family 26, subfamily c, polypeptide 1 |
17514 |
0.18 |
chr17_24722566_24722906 | 12.51 |
Ndufb10 |
NADH:ubiquinone oxidoreductase subunit B10 |
87 |
0.87 |
chr15_67143595_67143753 | 12.48 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
14651 |
0.25 |
chr12_59135982_59136133 | 12.48 |
Mia2 |
MIA SH3 domain ER export factor 2 |
52 |
0.96 |
chr11_119392756_119392927 | 12.45 |
Rnf213 |
ring finger protein 213 |
259 |
0.87 |
chr17_47578693_47578993 | 12.39 |
Ccnd3 |
cyclin D3 |
14593 |
0.11 |
chr11_4224313_4224503 | 12.35 |
Castor1 |
cytosolic arginine sensor for mTORC1 subunit 1 |
6183 |
0.1 |
chr4_32987000_32987211 | 12.27 |
Rragd |
Ras-related GTP binding D |
3651 |
0.16 |
chr5_139738073_139738523 | 12.23 |
Micall2 |
MICAL-like 2 |
1962 |
0.25 |
chr17_50024937_50025116 | 12.23 |
AC133946.1 |
oxidoreductase NAD-binding domain containing 1 (OXNAD1) pseudogene |
52199 |
0.12 |
chrX_48896914_48897080 | 12.20 |
Gm7219 |
predicted pseudogene 7219 |
6822 |
0.24 |
chr14_63124821_63124972 | 12.19 |
Ctsb |
cathepsin B |
2382 |
0.21 |
chr2_153608221_153608636 | 12.15 |
Commd7 |
COMM domain containing 7 |
24303 |
0.15 |
chr2_163555952_163556237 | 12.08 |
Hnf4a |
hepatic nuclear factor 4, alpha |
6011 |
0.14 |
chr2_60142375_60142548 | 12.08 |
Ldha-ps |
lactate dehydrogenase A, pseudogene |
8406 |
0.16 |
chr7_4744995_4745246 | 12.06 |
Kmt5c |
lysine methyltransferase 5C |
688 |
0.43 |
chr6_121097555_121097706 | 12.00 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
5905 |
0.17 |
chr6_135167388_135167622 | 11.98 |
Hebp1 |
heme binding protein 1 |
630 |
0.58 |
chr11_80873165_80873425 | 11.84 |
Spaca3 |
sperm acrosome associated 3 |
14923 |
0.18 |
chr7_114771406_114771557 | 11.82 |
Insc |
INSC spindle orientation adaptor protein |
160 |
0.96 |
chr9_60368037_60368202 | 11.79 |
Gm47676 |
predicted gene, 47676 |
25638 |
0.17 |
chr2_165982880_165983040 | 11.77 |
Platr29 |
pluripotency associated transcript 29 |
2964 |
0.18 |
chrX_164425306_164425513 | 11.50 |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
101 |
0.96 |
chr19_43782049_43782382 | 11.43 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
23 |
0.97 |
chr2_164769313_164769543 | 11.42 |
Gm11457 |
predicted gene 11457 |
191 |
0.71 |
chr9_65575273_65575466 | 11.42 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
1731 |
0.28 |
chr18_82492392_82492692 | 11.39 |
Mbp |
myelin basic protein |
17172 |
0.17 |
chr9_98280270_98280442 | 11.38 |
Nmnat3 |
nicotinamide nucleotide adenylyltransferase 3 |
7079 |
0.22 |
chr12_111353338_111354089 | 11.29 |
Cdc42bpb |
CDC42 binding protein kinase beta |
23906 |
0.13 |
chr6_137557024_137557206 | 11.22 |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
13644 |
0.23 |
chr5_137349031_137350198 | 11.21 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr11_115612108_115612347 | 11.18 |
Mif4gd |
MIF4G domain containing |
101 |
0.93 |
chr3_95518669_95518820 | 11.17 |
Ctss |
cathepsin S |
8042 |
0.1 |
chrX_8272065_8272343 | 11.17 |
Slc38a5 |
solute carrier family 38, member 5 |
562 |
0.69 |
chr5_140765336_140765550 | 11.16 |
Amz1 |
archaelysin family metallopeptidase 1 |
16160 |
0.18 |
chr3_51670694_51670977 | 11.14 |
Mgst2 |
microsomal glutathione S-transferase 2 |
628 |
0.59 |
chr8_122319734_122319919 | 11.14 |
Zfpm1 |
zinc finger protein, multitype 1 |
12506 |
0.12 |
chr10_87520827_87520978 | 11.14 |
Pah |
phenylalanine hydroxylase |
893 |
0.6 |
chr1_74971709_74972075 | 11.13 |
Gm37744 |
predicted gene, 37744 |
17640 |
0.11 |
chr4_117829604_117830012 | 11.10 |
Gm12842 |
predicted gene 12842 |
4152 |
0.14 |
chr3_137957469_137957620 | 11.03 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
1677 |
0.25 |
chrX_101290140_101290457 | 11.02 |
Med12 |
mediator complex subunit 12 |
2836 |
0.13 |
chr5_110230616_110231541 | 11.01 |
Ankle2 |
ankyrin repeat and LEM domain containing 2 |
37 |
0.59 |
chr8_11055553_11055917 | 11.01 |
9530052E02Rik |
RIKEN cDNA 9530052E02 gene |
6157 |
0.16 |
chr8_83423598_83423760 | 10.98 |
Scoc |
short coiled-coil protein |
14148 |
0.13 |
chr11_3170338_3170795 | 10.98 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
138 |
0.93 |
chr7_120980473_120980737 | 10.96 |
Cdr2 |
cerebellar degeneration-related 2 |
1185 |
0.29 |
chr5_140795308_140795523 | 10.93 |
Gna12 |
guanine nucleotide binding protein, alpha 12 |
34742 |
0.15 |
chr11_107342430_107342587 | 10.92 |
Gm11716 |
predicted gene 11716 |
4458 |
0.16 |
chr14_34349035_34349385 | 10.83 |
Gm3219 |
predicted pseudogene 3219 |
3929 |
0.13 |
chr17_26514334_26514507 | 10.82 |
Dusp1 |
dual specificity phosphatase 1 |
5901 |
0.11 |
chr4_108233759_108233910 | 10.81 |
Zyg11b |
zyg-ll family member B, cell cycle regulator |
8204 |
0.16 |
chr14_121425553_121425718 | 10.75 |
Gm33299 |
predicted gene, 33299 |
30127 |
0.14 |
chr5_134913432_134913583 | 10.75 |
Cldn13 |
claudin 13 |
2019 |
0.15 |
chr14_121145392_121145543 | 10.70 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
43388 |
0.18 |
chr16_8761036_8761187 | 10.69 |
Gm25805 |
predicted gene, 25805 |
5165 |
0.19 |
chr6_34875607_34875898 | 10.68 |
Cyren |
cell cycle regulator of NHEJ |
1228 |
0.33 |
chr9_66626113_66626277 | 10.60 |
Usp3 |
ubiquitin specific peptidase 3 |
33053 |
0.16 |
chr5_139794903_139795230 | 10.59 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
2448 |
0.18 |
chr11_4217876_4218712 | 10.53 |
Castor1 |
cytosolic arginine sensor for mTORC1 subunit 1 |
69 |
0.94 |
chr2_101979922_101980233 | 10.51 |
Gm13919 |
predicted gene 13919 |
59552 |
0.11 |
chr12_111518372_111518678 | 10.50 |
Gm40578 |
predicted gene, 40578 |
17685 |
0.1 |
chr10_75789858_75790063 | 10.49 |
Gstt1 |
glutathione S-transferase, theta 1 |
7609 |
0.09 |
chr11_94630351_94630909 | 10.45 |
Lrrc59 |
leucine rich repeat containing 59 |
816 |
0.45 |
chr11_5499263_5499558 | 10.45 |
Gm11963 |
predicted gene 11963 |
570 |
0.67 |
chr11_58095756_58095918 | 10.44 |
Gm12247 |
predicted gene 12247 |
1936 |
0.2 |
chr17_32455147_32455312 | 10.41 |
Cyp4f39 |
cytochrome P450, family 4, subfamily f, polypeptide 39 |
2477 |
0.2 |
chr5_65476804_65477100 | 10.36 |
Gm43290 |
predicted gene 43290 |
1109 |
0.32 |
chr11_62006277_62006428 | 10.28 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
1002 |
0.52 |
chr11_77753547_77753707 | 10.24 |
Gm11191 |
predicted gene 11191 |
6586 |
0.14 |
chr4_11005275_11005523 | 10.16 |
Plekhf2 |
pleckstrin homology domain containing, family F (with FYVE domain) member 2 |
2277 |
0.29 |
chr4_123286418_123286738 | 10.16 |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
3483 |
0.12 |
chr5_37456665_37456895 | 10.13 |
Evc2 |
EvC ciliary complex subunit 2 |
40921 |
0.16 |
chr5_130255007_130255346 | 10.13 |
Sbds |
SBDS ribosome maturation factor |
229 |
0.68 |
chr9_21030077_21030479 | 10.12 |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
824 |
0.29 |
chr2_166116203_166116481 | 10.11 |
Sulf2 |
sulfatase 2 |
38081 |
0.13 |
chr7_19692836_19692987 | 10.11 |
Apoc1 |
apolipoprotein C-I |
251 |
0.79 |
chr9_67037424_67037591 | 10.04 |
Tpm1 |
tropomyosin 1, alpha |
4682 |
0.2 |
chr17_34898151_34899707 | 10.03 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr17_35258226_35258490 | 10.00 |
H2-D1 |
histocompatibility 2, D region locus 1 |
4372 |
0.06 |
chr11_58018809_58018969 | 9.97 |
Larp1 |
La ribonucleoprotein domain family, member 1 |
9825 |
0.15 |
chr15_81853519_81853670 | 9.95 |
Gm49476 |
predicted gene, 49476 |
4147 |
0.1 |
chr2_157130956_157131107 | 9.92 |
Samhd1 |
SAM domain and HD domain, 1 |
974 |
0.5 |
chr2_152117776_152118040 | 9.92 |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
12384 |
0.14 |
chr15_36640378_36640529 | 9.87 |
Gm6704 |
predicted gene 6704 |
10584 |
0.13 |
chr8_124569694_124570048 | 9.85 |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
165 |
0.95 |
chr6_86437772_86437939 | 9.81 |
C87436 |
expressed sequence C87436 |
519 |
0.61 |
chr12_82914251_82914402 | 9.76 |
1700085C21Rik |
RIKEN cDNA 1700085C21 gene |
24829 |
0.21 |
chr10_128344618_128344789 | 9.73 |
Gm23182 |
predicted gene, 23182 |
4538 |
0.07 |
chr5_74062664_74062828 | 9.71 |
Gm43415 |
predicted gene 43415 |
2708 |
0.15 |
chr10_43291290_43291458 | 9.66 |
Gm16546 |
predicted gene 16546 |
27986 |
0.15 |
chr8_25617928_25618094 | 9.64 |
Gm23184 |
predicted gene, 23184 |
7453 |
0.1 |
chr17_43024715_43025051 | 9.57 |
Tnfrsf21 |
tumor necrosis factor receptor superfamily, member 21 |
8315 |
0.3 |
chr2_131213938_131214219 | 9.56 |
Ap5s1 |
adaptor-related protein 5 complex, sigma 1 subunit |
3474 |
0.13 |
chr17_33807244_33807395 | 9.51 |
Kank3 |
KN motif and ankyrin repeat domains 3 |
3200 |
0.1 |
chr4_108318238_108318389 | 9.46 |
Gm12740 |
predicted gene 12740 |
4025 |
0.15 |
chr8_105303476_105303637 | 9.46 |
E2f4 |
E2F transcription factor 4 |
369 |
0.61 |
chr10_84621933_84622115 | 9.45 |
Polr3b |
polymerase (RNA) III (DNA directed) polypeptide B |
268 |
0.71 |
chr11_4236304_4236455 | 9.45 |
Osm |
oncostatin M |
41 |
0.95 |
chr3_159495249_159496136 | 9.44 |
Depdc1a |
DEP domain containing 1a |
234 |
0.94 |
chr9_50811689_50812054 | 9.39 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
3192 |
0.18 |
chr17_47754107_47754296 | 9.39 |
Tfeb |
transcription factor EB |
125 |
0.94 |
chr9_120132993_120133144 | 9.37 |
Gm5922 |
predicted gene 5922 |
1947 |
0.13 |
chr11_61959132_61959283 | 9.35 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
2392 |
0.2 |
chr18_36773274_36773433 | 9.33 |
Hars |
histidyl-tRNA synthetase |
3126 |
0.1 |
chr2_139906971_139907122 | 9.32 |
Gm14070 |
predicted gene 14070 |
43749 |
0.18 |
chr11_7153175_7153391 | 9.30 |
Adcy1 |
adenylate cyclase 1 |
6599 |
0.21 |
chr4_82815311_82815597 | 9.29 |
Zdhhc21 |
zinc finger, DHHC domain containing 21 |
35360 |
0.17 |
chr19_8672878_8673070 | 9.28 |
Chrm1 |
cholinergic receptor, muscarinic 1, CNS |
8969 |
0.07 |
chr3_153905538_153906361 | 9.25 |
Msh4 |
mutS homolog 4 |
189 |
0.87 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.9 | 8.7 | GO:0036166 | phenotypic switching(GO:0036166) |
2.8 | 11.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
2.6 | 7.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
2.6 | 13.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
2.6 | 10.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.5 | 7.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
2.4 | 7.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.3 | 9.3 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
2.3 | 6.9 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.3 | 6.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
2.3 | 9.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
2.2 | 6.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.0 | 6.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
2.0 | 6.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
2.0 | 19.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
2.0 | 5.9 | GO:0031627 | telomeric loop formation(GO:0031627) |
2.0 | 5.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.9 | 5.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.9 | 5.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.9 | 5.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.9 | 7.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.8 | 11.1 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.8 | 5.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.8 | 7.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.8 | 5.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.8 | 5.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.8 | 5.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.8 | 8.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 7.0 | GO:0006188 | IMP biosynthetic process(GO:0006188) purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
1.7 | 15.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.7 | 5.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.6 | 4.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
1.6 | 4.9 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.6 | 4.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.6 | 4.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.6 | 4.8 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.6 | 6.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.5 | 4.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.5 | 10.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.5 | 1.5 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.5 | 7.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.5 | 16.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.5 | 4.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.4 | 7.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.4 | 4.3 | GO:0090135 | actin filament branching(GO:0090135) |
1.4 | 4.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.4 | 5.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.4 | 4.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.4 | 9.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.4 | 5.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.4 | 12.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.3 | 5.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.3 | 7.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.3 | 32.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.3 | 2.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.3 | 11.5 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
1.3 | 6.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
1.3 | 7.6 | GO:0033572 | transferrin transport(GO:0033572) |
1.3 | 32.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.3 | 3.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.2 | 5.0 | GO:0009597 | detection of virus(GO:0009597) |
1.2 | 9.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.2 | 4.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.2 | 4.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.2 | 3.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.2 | 4.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.2 | 3.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.1 | 3.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.1 | 1.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.1 | 2.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.1 | 4.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.1 | 4.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.1 | 3.3 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
1.1 | 3.3 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.1 | 1.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
1.1 | 3.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.1 | 4.2 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.1 | 19.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.1 | 3.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.1 | 5.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.1 | 3.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.1 | 8.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
1.0 | 5.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.0 | 3.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.0 | 4.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.0 | 3.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.0 | 4.1 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.0 | 13.3 | GO:0045116 | protein neddylation(GO:0045116) |
1.0 | 4.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.0 | 2.9 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.0 | 1.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.0 | 2.9 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
1.0 | 6.8 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.0 | 2.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.0 | 8.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.9 | 2.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.9 | 3.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.9 | 2.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.9 | 9.2 | GO:0015816 | glycine transport(GO:0015816) |
0.9 | 3.7 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.9 | 2.7 | GO:0008228 | opsonization(GO:0008228) |
0.9 | 1.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.9 | 2.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.9 | 2.7 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.9 | 20.6 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.9 | 4.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.9 | 4.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.9 | 2.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.9 | 0.9 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.9 | 10.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.9 | 2.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.9 | 2.6 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 2.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.9 | 3.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.8 | 3.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.8 | 2.5 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.8 | 2.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.8 | 2.5 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.8 | 3.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.8 | 2.5 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.8 | 1.7 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.8 | 7.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.8 | 4.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.8 | 5.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 3.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 5.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.8 | 2.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 2.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.8 | 4.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.8 | 1.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.8 | 15.4 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.8 | 4.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.8 | 6.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.8 | 4.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.8 | 4.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.8 | 2.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.8 | 1.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.8 | 2.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.8 | 2.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 1.6 | GO:1905049 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.8 | 4.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.8 | 1.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.8 | 2.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.8 | 0.8 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.8 | 9.9 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.8 | 2.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.8 | 6.8 | GO:0043486 | histone exchange(GO:0043486) |
0.8 | 2.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.8 | 1.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.8 | 4.5 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
0.8 | 2.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.8 | 4.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.8 | 4.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.7 | 2.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.7 | 2.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 4.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.7 | 9.6 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.7 | 5.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.7 | 2.9 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.7 | 3.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.7 | 0.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.7 | 2.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.7 | 5.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.7 | 9.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.7 | 1.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 1.4 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.7 | 3.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.7 | 5.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 2.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.7 | 2.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.7 | 2.1 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.7 | 2.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.7 | 0.7 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.7 | 2.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.7 | 4.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.7 | 5.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.7 | 0.7 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.7 | 4.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.7 | 6.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 0.7 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.7 | 2.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.7 | 1.3 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.7 | 2.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.7 | 2.0 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.7 | 3.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 1.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.6 | 3.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 0.6 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.6 | 1.9 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.6 | 3.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.6 | 0.6 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.6 | 3.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.6 | 2.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.6 | 3.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 4.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.6 | 2.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.6 | 18.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.6 | 1.3 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.6 | 5.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.6 | 2.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.6 | 1.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.6 | 3.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.6 | 4.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.6 | 1.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 1.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 1.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.6 | 0.6 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.6 | 10.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.6 | 1.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.6 | 1.2 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.6 | 0.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.6 | 1.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 3.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.6 | 1.8 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 4.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.6 | 4.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.6 | 8.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.6 | 1.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.6 | 4.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.6 | 6.4 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.6 | 0.6 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.6 | 1.7 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.6 | 1.7 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.6 | 1.7 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.6 | 1.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.6 | 0.6 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.6 | 1.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 3.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.6 | 0.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.6 | 2.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 5.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 1.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.5 | 1.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.5 | 1.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.5 | 1.6 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.5 | 0.5 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.5 | 1.6 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.5 | 4.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.5 | 2.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.5 | 1.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 3.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 1.6 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.5 | 36.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.5 | 1.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 1.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 1.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 1.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 1.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.5 | 1.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.5 | 1.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 2.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.5 | 1.0 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 2.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 3.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 1.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.5 | 24.2 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.5 | 1.5 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.5 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 0.5 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.5 | 2.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 0.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.5 | 1.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 4.5 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.5 | 2.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.5 | 1.5 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.5 | 2.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.5 | 1.0 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.5 | 1.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 1.5 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.5 | 1.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.5 | 4.8 | GO:0046697 | decidualization(GO:0046697) |
0.5 | 1.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 0.5 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.5 | 0.9 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.5 | 1.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.5 | 8.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.5 | 2.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 2.3 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.5 | 0.9 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 0.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.5 | 0.5 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.5 | 0.5 | GO:1901563 | response to camptothecin(GO:1901563) |
0.5 | 6.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.5 | 0.5 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.5 | 2.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.5 | 1.4 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.5 | 5.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.5 | 3.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.5 | 1.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 1.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.4 | 0.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 0.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 1.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 3.6 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.4 | 0.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 1.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 0.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.4 | 1.8 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.4 | 4.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.4 | 1.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 0.4 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.4 | 1.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.4 | 1.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 2.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 0.4 | GO:0048143 | astrocyte activation(GO:0048143) |
0.4 | 1.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 2.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.4 | 1.7 | GO:0002159 | desmosome assembly(GO:0002159) |
0.4 | 1.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.4 | 2.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.4 | 1.3 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.4 | 0.9 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.4 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.4 | 2.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 7.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.4 | 0.9 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.4 | 2.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.4 | 2.6 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.4 | 2.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 2.6 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.4 | 5.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 1.7 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.4 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 4.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.4 | 0.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 | 10.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.4 | 2.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.4 | 1.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 1.7 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.4 | 1.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 8.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.4 | 4.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 1.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 | 26.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.4 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 3.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.4 | 1.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.4 | 4.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 1.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.4 | 0.4 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.4 | 0.8 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.4 | 1.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 2.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 4.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 0.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 3.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.4 | 0.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 1.6 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.4 | 0.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 4.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 0.8 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 0.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.4 | 1.2 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.4 | 1.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 3.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.4 | 8.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.4 | 2.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 1.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.4 | 1.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 1.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.4 | 0.8 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.4 | 0.4 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.4 | 1.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 0.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.4 | 1.9 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.4 | 1.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 0.8 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 0.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 4.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 2.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.4 | 4.1 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.4 | 1.5 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 9.0 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.4 | 2.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 1.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.4 | 1.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 9.6 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.4 | 1.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 1.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 1.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 2.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 2.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 1.5 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 0.7 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.4 | 6.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.4 | 1.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 0.7 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.4 | 1.1 | GO:0046618 | drug export(GO:0046618) |
0.4 | 0.7 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.4 | 2.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 8.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 1.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 3.2 | GO:1901070 | GTP biosynthetic process(GO:0006183) guanosine-containing compound biosynthetic process(GO:1901070) |
0.4 | 1.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 2.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 1.8 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.4 | 1.4 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.4 | 1.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 10.8 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 1.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 1.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 1.0 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 1.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.3 | 2.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 1.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 1.0 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.3 | 1.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.3 | 1.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.3 | 0.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 2.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.3 | 0.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.3 | 0.7 | GO:0051593 | response to folic acid(GO:0051593) |
0.3 | 1.7 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.3 | 2.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 7.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 0.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.3 | 7.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 0.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.3 | 5.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 2.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 1.0 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.3 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 1.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 1.0 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 2.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 0.6 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.6 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 1.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 0.9 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.3 | 0.9 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.9 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 0.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 0.6 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 2.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 0.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 0.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 1.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.3 | 2.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 1.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 3.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 1.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 2.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.3 | 0.6 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.3 | 2.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.3 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.3 | 1.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.9 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 2.7 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.3 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 0.9 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 0.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 1.8 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 1.2 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
0.3 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 1.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 4.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 7.9 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.3 | 2.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.3 | 0.6 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.3 | 4.4 | GO:0007031 | peroxisome organization(GO:0007031) |
0.3 | 0.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 0.6 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.3 | 2.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 0.6 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.3 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 3.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 0.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.3 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 0.3 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 1.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 1.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.3 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 5.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 2.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 1.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 1.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 2.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 3.9 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.3 | 0.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 0.5 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.3 | 1.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 1.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 0.8 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 0.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 0.5 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.3 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.8 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.3 | 3.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.3 | 1.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 1.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 0.5 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.3 | 0.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 0.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.3 | 4.0 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.3 | 1.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 10.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 0.3 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
0.3 | 1.6 | GO:0033574 | response to testosterone(GO:0033574) |
0.3 | 1.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.3 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 1.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.5 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.3 | 4.7 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.3 | 1.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 1.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 1.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 1.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 0.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 3.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 0.5 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 1.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 1.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.3 | 1.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 4.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 1.5 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.3 | 1.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 1.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 1.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 3.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 4.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.7 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.7 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.2 | 0.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 2.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 1.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.2 | 0.2 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
0.2 | 1.7 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 2.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.7 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.2 | 0.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 2.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.7 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.5 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 3.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.7 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 2.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 1.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.2 | GO:0032608 | interferon-beta production(GO:0032608) |
0.2 | 0.5 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.2 | 0.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 0.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 0.5 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 2.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 2.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 2.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.9 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 2.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.6 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 3.6 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 2.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 0.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 3.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.2 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 2.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 1.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 3.3 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.2 | 1.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 2.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 1.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 3.3 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 3.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 2.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 3.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.7 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.4 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 0.7 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 0.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 1.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.6 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 2.8 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.2 | 0.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 0.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.2 | 0.6 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 1.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.2 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 0.4 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 2.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.6 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.2 | 6.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 4.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 1.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.2 | 2.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 5.0 | GO:0060323 | head morphogenesis(GO:0060323) |
0.2 | 0.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 2.3 | GO:1903727 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) positive regulation of phospholipid metabolic process(GO:1903727) |
0.2 | 0.4 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 2.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 12.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 0.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 7.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.4 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.2 | 3.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 9.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 5.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 2.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 5.8 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
0.2 | 1.0 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 3.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 2.8 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.4 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 0.8 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 2.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.2 | 11.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 0.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 1.5 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.2 | 0.2 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 0.8 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.2 | 1.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.6 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 2.5 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 1.3 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.2 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.2 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.2 | 1.5 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.6 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 2.0 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.2 | 0.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 1.5 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.2 | 2.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 0.7 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 1.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.5 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.2 | 1.5 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.4 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.2 | 0.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.4 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.2 | 0.2 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 1.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 4.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 1.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 0.2 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 1.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.7 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 11.2 | GO:0098792 | xenophagy(GO:0098792) |
0.2 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 2.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 1.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 2.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 1.9 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.7 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.9 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 0.5 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 0.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.7 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 2.9 | GO:0001562 | response to protozoan(GO:0001562) |
0.2 | 0.3 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.2 | 0.8 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 0.3 | GO:0001774 | microglial cell activation(GO:0001774) |
0.2 | 0.5 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.2 | 1.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.2 | 0.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 0.3 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.7 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.2 | 0.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 1.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.5 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 1.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.2 | 3.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 1.8 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.2 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.5 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
0.2 | 0.5 | GO:1902267 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 2.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 1.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.8 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 2.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 1.9 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.5 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.2 | 4.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 4.2 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 2.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 1.7 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.2 | 1.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.8 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.2 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 1.8 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 2.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.9 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 1.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.4 | GO:0032303 | regulation of icosanoid secretion(GO:0032303) |
0.1 | 4.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 1.6 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.1 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 3.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.4 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.3 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 2.3 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 1.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 1.0 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.3 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.1 | 1.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.1 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.4 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 1.0 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.3 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.1 | 2.8 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.4 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.4 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.1 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 4.2 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.1 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.1 | 4.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.7 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.1 | 1.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 1.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 3.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.4 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 1.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 1.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 5.7 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 2.6 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.1 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 2.7 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 2.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 1.7 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 2.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) glyoxylate metabolic process(GO:0046487) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 1.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.6 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.6 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 2.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 1.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.2 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 1.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 1.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.6 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 1.0 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 1.3 | GO:0006476 | protein deacetylation(GO:0006476) |
0.1 | 3.0 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.1 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.1 | 1.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 1.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.6 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.1 | 0.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 1.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 3.3 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.2 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 1.5 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.1 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 1.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) |
0.1 | 0.8 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.3 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.1 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 0.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 1.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 1.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.3 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.1 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.2 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.4 | GO:0098751 | bone cell development(GO:0098751) |
0.1 | 0.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 1.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 1.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.3 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.6 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.2 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.1 | GO:0072008 | regulation of vascular wound healing(GO:0061043) glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 1.0 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 0.1 | GO:0009415 | response to water(GO:0009415) |
0.1 | 0.5 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.1 | 0.6 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.1 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.1 | 0.5 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.2 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.2 | GO:0071354 | response to interleukin-6(GO:0070741) cellular response to interleukin-6(GO:0071354) |
0.1 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.8 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.1 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.1 | 0.6 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 1.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.1 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 1.0 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.8 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.1 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 4.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.1 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 1.3 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.1 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 3.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.2 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 1.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.3 | GO:1900408 | negative regulation of cellular response to oxidative stress(GO:1900408) negative regulation of response to oxidative stress(GO:1902883) negative regulation of oxidative stress-induced cell death(GO:1903202) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 1.0 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.1 | GO:0090193 | positive regulation of glomerulus development(GO:0090193) |
0.1 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.6 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.2 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.1 | 0.3 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 1.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.6 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 0.2 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.1 | 0.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.0 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.0 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 1.2 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.1 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.1 | GO:0031100 | organ regeneration(GO:0031100) |
0.0 | 0.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.2 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 1.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.0 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.1 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.0 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.0 | 0.5 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.1 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.1 | GO:2000380 | regulation of mesoderm development(GO:2000380) |
0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 1.1 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.0 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.0 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.0 | 0.0 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.2 | GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.0 | 0.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.0 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.0 | 0.0 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.0 | 0.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0071715 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.0 | 0.0 | GO:0006901 | vesicle coating(GO:0006901) |
0.0 | 0.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
0.0 | 0.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.0 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) |
0.0 | 0.1 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.0 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.2 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 1.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.0 | 0.2 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 1.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.2 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.1 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.7 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
0.0 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.0 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0098534 | centriole assembly(GO:0098534) |
0.0 | 0.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.1 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.0 | 0.0 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) multicellular organismal water homeostasis(GO:0050891) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.0 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.1 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.1 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.0 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.0 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.0 | 0.6 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.0 | GO:2001021 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.0 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.0 | 0.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.0 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.0 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.0 | 0.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0097503 | sialylation(GO:0097503) negative regulation of macrophage apoptotic process(GO:2000110) |
0.0 | 0.0 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.0 | 0.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.0 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 3.5 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.0 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.0 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.0 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.0 | 0.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.0 | 0.7 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.5 | 10.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.5 | 7.5 | GO:0000811 | GINS complex(GO:0000811) |
2.4 | 12.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.4 | 12.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.1 | 17.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
2.0 | 6.1 | GO:0097427 | microtubule bundle(GO:0097427) |
1.7 | 5.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.6 | 4.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.6 | 1.6 | GO:0005914 | spot adherens junction(GO:0005914) |
1.5 | 4.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.5 | 1.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.5 | 4.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.5 | 4.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.4 | 5.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.4 | 8.4 | GO:0001940 | male pronucleus(GO:0001940) |
1.3 | 5.3 | GO:0071797 | LUBAC complex(GO:0071797) |
1.3 | 5.3 | GO:0030689 | Noc complex(GO:0030689) |
1.3 | 13.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.3 | 2.6 | GO:0001939 | female pronucleus(GO:0001939) |
1.2 | 6.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.2 | 5.9 | GO:0030870 | Mre11 complex(GO:0030870) |
1.1 | 3.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.1 | 1.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.1 | 3.3 | GO:0097413 | Lewy body(GO:0097413) |
1.1 | 3.3 | GO:0097443 | sorting endosome(GO:0097443) |
1.1 | 4.3 | GO:0070545 | PeBoW complex(GO:0070545) |
1.0 | 10.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.0 | 10.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.0 | 15.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.0 | 3.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.0 | 4.9 | GO:0070187 | telosome(GO:0070187) |
1.0 | 4.8 | GO:0008091 | spectrin(GO:0008091) |
0.9 | 3.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.9 | 2.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.9 | 2.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.9 | 5.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.9 | 9.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.9 | 3.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 1.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.9 | 4.3 | GO:0033503 | HULC complex(GO:0033503) |
0.8 | 2.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.8 | 9.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.8 | 2.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.8 | 4.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.8 | 0.8 | GO:1990423 | RZZ complex(GO:1990423) |
0.8 | 1.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.7 | 6.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 14.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.7 | 4.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 2.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.7 | 6.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.7 | 7.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.7 | 2.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 3.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 4.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.7 | 7.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.7 | 11.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 12.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.7 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 1.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.7 | 4.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.6 | 2.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 3.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.6 | 5.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.6 | 3.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.6 | 1.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 2.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.6 | 1.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.6 | 1.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.6 | 2.4 | GO:0072487 | MSL complex(GO:0072487) |
0.6 | 4.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.6 | 12.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.6 | 2.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.6 | 1.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 7.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.6 | 16.2 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 6.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 3.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.5 | 2.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 22.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.5 | 1.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 4.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.5 | 6.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 1.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.5 | 2.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 1.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.5 | 9.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 1.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.5 | 0.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 11.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 1.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 4.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 5.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 3.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 3.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.5 | 4.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 8.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 1.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 1.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 31.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 3.5 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 6.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 1.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 2.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 16.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 17.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 0.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 1.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 3.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 3.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 3.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.4 | 5.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 1.9 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 2.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 2.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 1.5 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 33.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 4.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 3.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 1.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 2.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.4 | 1.1 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 23.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 1.8 | GO:0005818 | aster(GO:0005818) |
0.4 | 1.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 2.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 11.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 15.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 2.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 3.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 1.7 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 2.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 9.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 3.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 3.0 | GO:0002102 | podosome(GO:0002102) |
0.3 | 3.0 | GO:0032797 | SMN complex(GO:0032797) |
0.3 | 1.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 4.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 2.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 2.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 4.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 6.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 2.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 1.6 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 2.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 15.5 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 4.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.3 | 0.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 3.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 1.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 1.2 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 1.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 3.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 6.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 4.3 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 19.2 | GO:0000776 | kinetochore(GO:0000776) |
0.3 | 2.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 0.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 2.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 2.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 38.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 3.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 7.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 8.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.3 | 7.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 18.0 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.3 | 1.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 2.1 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 11.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 2.0 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 2.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 6.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 3.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 4.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 8.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 3.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 1.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 12.0 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.9 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 5.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 1.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 1.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 4.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 2.4 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 30.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.4 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 20.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 2.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 56.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 1.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 3.7 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 12.0 | GO:0005635 | nuclear envelope(GO:0005635) |
0.2 | 1.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 2.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 1.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 1.1 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 16.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 2.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 6.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 2.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 1.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 9.5 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 6.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 4.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 2.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 0.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 2.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 48.1 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 19.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.2 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.2 | 15.1 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 11.4 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.3 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 1.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.9 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 3.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 12.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 1.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 8.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 8.1 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 10.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 1.7 | GO:0043205 | fibril(GO:0043205) |
0.1 | 3.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 54.4 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 2.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 4.4 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 4.5 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.1 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.6 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 2.9 | GO:0030496 | midbody(GO:0030496) |
0.1 | 1.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 90.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 20.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 1.9 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.2 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.5 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.6 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 5.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 4.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 1.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.9 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 3.3 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 18.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 2.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 55.4 | GO:0031981 | nuclear lumen(GO:0031981) |
0.1 | 0.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.7 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 73.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 2.3 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 3.8 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 1.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 1.5 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.0 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 3.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 3.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.0 | GO:0031967 | organelle envelope(GO:0031967) |
0.0 | 0.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 13.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
2.4 | 22.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.3 | 7.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.3 | 6.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.2 | 15.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.1 | 6.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.9 | 7.6 | GO:0043515 | kinetochore binding(GO:0043515) |
1.8 | 7.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.8 | 7.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.8 | 5.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.8 | 8.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.7 | 5.0 | GO:0035877 | death effector domain binding(GO:0035877) |
1.6 | 11.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.6 | 8.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.6 | 6.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.6 | 4.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.6 | 4.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.6 | 4.7 | GO:0005119 | smoothened binding(GO:0005119) |
1.5 | 4.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.5 | 4.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.5 | 4.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.5 | 7.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.5 | 4.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.5 | 7.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.4 | 4.3 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.4 | 5.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.4 | 5.6 | GO:0030984 | kininogen binding(GO:0030984) |
1.4 | 4.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.4 | 4.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.4 | 2.8 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.4 | 5.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.4 | 4.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.3 | 9.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.3 | 3.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.3 | 7.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.3 | 5.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.2 | 3.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.2 | 2.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.2 | 7.2 | GO:0050733 | RS domain binding(GO:0050733) |
1.2 | 4.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.1 | 11.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.1 | 5.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 6.5 | GO:0004064 | arylesterase activity(GO:0004064) |
1.1 | 3.2 | GO:0004802 | transketolase activity(GO:0004802) |
1.1 | 2.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.1 | 2.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.1 | 3.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.0 | 9.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.0 | 4.0 | GO:0031014 | troponin T binding(GO:0031014) |
1.0 | 5.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.0 | 8.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.0 | 6.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.0 | 8.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.0 | 2.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.0 | 2.9 | GO:0016015 | morphogen activity(GO:0016015) |
1.0 | 1.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.9 | 4.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.9 | 2.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.9 | 15.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.9 | 10.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.9 | 4.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.9 | 8.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.9 | 2.6 | GO:0052622 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.9 | 3.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.9 | 2.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.9 | 6.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.9 | 4.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.9 | 2.6 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.8 | 2.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.8 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.8 | 7.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.8 | 4.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.8 | 4.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.8 | 7.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.8 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.8 | 8.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.8 | 2.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.7 | 17.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.7 | 2.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 3.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.7 | 5.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 2.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.7 | 1.4 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.7 | 2.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 9.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.7 | 2.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.7 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.7 | 2.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 7.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.7 | 2.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.7 | 4.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.7 | 11.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 2.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.7 | 6.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 12.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 2.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 2.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 2.6 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.7 | 2.6 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.6 | 8.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.6 | 1.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 4.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.6 | 7.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.6 | 3.8 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.6 | 2.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 1.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 1.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 2.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 4.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 11.2 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 1.9 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 0.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.6 | 1.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 2.3 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 7.0 | GO:0043176 | amine binding(GO:0043176) |
0.6 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.6 | 1.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.6 | 8.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 12.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.6 | 1.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 4.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 7.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 4.5 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 1.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.6 | 8.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.6 | 11.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 3.9 | GO:0018641 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 1.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 5.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 6.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 2.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.5 | 8.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 1.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 1.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 1.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 2.6 | GO:0070728 | leucine binding(GO:0070728) |
0.5 | 3.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 3.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 1.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.5 | 3.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.5 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 4.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 3.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 7.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 2.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 1.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 5.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 2.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 1.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 1.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.5 | 5.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 2.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.5 | 1.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.5 | 5.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.5 | 4.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.5 | 0.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 5.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.5 | 3.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.5 | 2.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 2.8 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.5 | 2.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.5 | 2.8 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.5 | 4.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 3.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 4.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.5 | 1.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.5 | 1.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 2.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 4.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 1.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 1.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 2.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 6.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 2.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 3.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.4 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 3.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 3.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 1.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.4 | 5.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 2.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.4 | 1.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 1.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 8.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 1.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 7.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 1.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.4 | 4.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 4.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.6 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 3.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 1.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 1.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.4 | 1.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 4.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 1.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 3.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 6.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 7.8 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 1.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 6.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 6.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 14.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 0.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 1.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.4 | 2.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 10.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 4.6 | GO:0005542 | folic acid binding(GO:0005542) |
0.4 | 1.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 0.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 3.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 11.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.3 | 1.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 1.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 2.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 1.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 2.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.3 | 1.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 1.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 2.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.3 | 49.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.3 | 10.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 3.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 1.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 3.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 1.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 2.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 5.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 34.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 1.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 1.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 0.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 3.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 0.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.9 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 0.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 0.3 | GO:0035276 | ethanol binding(GO:0035276) |
0.3 | 4.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 4.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 7.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 1.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 1.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 0.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 0.6 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 0.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 5.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 8.5 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.3 | 1.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 1.1 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 4.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 12.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 0.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 3.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 6.8 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 1.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 4.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.3 | 6.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 5.6 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 6.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 7.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 1.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 0.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.3 | 1.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.3 | 5.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 6.8 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 1.6 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 2.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 1.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 2.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 0.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 9.8 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 0.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 2.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 6.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 1.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 1.2 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 3.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 4.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 8.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 2.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 3.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 1.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 1.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 2.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 4.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 3.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 2.1 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 5.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 8.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 3.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 2.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 0.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 36.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 8.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 1.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 2.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.2 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.2 | 16.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 2.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 1.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 11.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 1.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.2 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 12.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 4.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 2.6 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 1.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 10.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 1.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.4 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 2.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.6 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.2 | 2.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 3.1 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 0.7 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 1.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 0.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 1.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 3.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 3.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 0.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 1.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 8.8 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.2 | 0.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 2.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 3.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 4.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.2 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 0.2 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 4.4 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 3.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 2.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 1.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 6.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 1.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.9 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 0.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 7.8 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 1.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 5.2 | GO:0016829 | lyase activity(GO:0016829) |
0.1 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 2.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 1.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 3.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 2.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.6 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 2.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.8 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 1.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 1.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.2 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.1 | 2.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 3.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 3.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 1.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 1.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 20.3 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 3.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 5.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 24.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.5 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 3.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 7.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.6 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 8.0 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 1.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 3.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 10.6 | GO:0046906 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
0.1 | 2.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 2.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 3.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 71.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.2 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.1 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 3.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 5.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.6 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 7.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 13.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 3.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 15.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 2.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 1.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 15.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.6 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.7 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.5 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.8 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 6.7 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 1.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.7 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.4 | GO:0016405 | acyl-CoA ligase activity(GO:0003996) succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) CoA-ligase activity(GO:0016405) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 8.6 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 10.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.9 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 1.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.4 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 1.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.3 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 4.8 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 1.6 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 1.7 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.0 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 16.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.0 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.0 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 14.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 21.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.7 | 8.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.7 | 38.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.7 | 15.9 | PID MYC PATHWAY | C-MYC pathway |
0.6 | 12.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 1.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.6 | 5.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 15.1 | PID ATM PATHWAY | ATM pathway |
0.5 | 2.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 13.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 2.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 8.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 7.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 3.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 10.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 16.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 6.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 6.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 5.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 20.8 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 15.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 15.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 10.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 4.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 0.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 4.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 4.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 2.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 3.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 4.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 6.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 3.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 10.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 4.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 6.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 14.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 3.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 2.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 5.5 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 8.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 7.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 2.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 9.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 7.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 6.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 3.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 4.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 1.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 0.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 4.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 3.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 2.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 3.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 3.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 5.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 6.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 3.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 1.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 2.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 1.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 1.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 4.3 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 1.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 2.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 0.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 4.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 1.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 5.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 2.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 5.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 3.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 5.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 2.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 4.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 5.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 21.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.3 | 12.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.2 | 14.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.1 | 15.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.1 | 2.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
1.0 | 17.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.0 | 1.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.0 | 4.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
1.0 | 2.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.9 | 21.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 10.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.9 | 0.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 12.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.7 | 7.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.7 | 7.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.7 | 4.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 17.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.7 | 7.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.6 | 14.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 5.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.6 | 7.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 7.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.6 | 41.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 8.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 6.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 4.7 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.5 | 0.5 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.5 | 19.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.5 | 8.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 2.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.5 | 6.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 8.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 2.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 0.5 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.5 | 9.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.5 | 9.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 6.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 5.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 0.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.5 | 9.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 10.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.5 | 10.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.5 | 1.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 3.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 3.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.4 | 7.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 3.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 0.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.4 | 2.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 2.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 2.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 12.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 2.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 9.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 2.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.4 | 8.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 3.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 8.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.4 | 10.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 16.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.4 | 3.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 3.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 3.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 10.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 1.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.4 | 13.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 0.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.3 | 2.1 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.3 | 5.9 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.3 | 1.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 4.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 4.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 5.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 17.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 3.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 3.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 9.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 7.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 2.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 1.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 0.3 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.3 | 7.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 3.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 1.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 6.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 19.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 4.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 7.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 4.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 2.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 2.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 23.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 4.9 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 0.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 5.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 4.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 2.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 26.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 1.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 2.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 8.7 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.3 | 2.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 2.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 5.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 8.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 6.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 2.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 3.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 2.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 1.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 10.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 2.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 2.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 3.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 1.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 3.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 2.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 8.8 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 5.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 8.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 0.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 8.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 1.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 3.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 3.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 4.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 1.5 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.2 | 0.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 0.4 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 2.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 1.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 1.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 22.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 5.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 2.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 2.1 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 5.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 4.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 2.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 1.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 9.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 6.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.9 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 1.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.6 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 1.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.5 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 2.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 4.6 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 1.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 2.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 1.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 6.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 2.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.1 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |